157 related articles for article (PubMed ID: 10884597)
1. Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice.
Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T
Int J Dev Neurosci; 2000 Oct; 18(6):521-30. PubMed ID: 10884597
[TBL] [Abstract][Full Text] [Related]
2. Relationship between methamphetamine-induced dopamine release, hyperthermia, self-injurious behaviour and long term dopamine depletion in BALB/c and C57BL/6 mice.
Halladay AK; Kusnecov A; Michna L; Kita T; Hara C; Wagner GC
Pharmacol Toxicol; 2003 Jul; 93(1):33-41. PubMed ID: 12828572
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effects of alpha-phenyl-N-tert-butyl nitrone pretreatment on the neurobehavioral effects of methamphetamine.
Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T
Life Sci; 2000 Aug; 67(13):1559-71. PubMed ID: 10983851
[TBL] [Abstract][Full Text] [Related]
4. Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine.
Baldwin HA; Colado MI; Murray TK; De Souza RJ; Green AR
Br J Pharmacol; 1993 Mar; 108(3):590-6. PubMed ID: 8467354
[TBL] [Abstract][Full Text] [Related]
5. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity.
Kita T; Saraya T; Konishi N; Matsunari Y; Shimada K; Nakamura M; O'Hara K; Wagner GC; Nakashima T
Pharmacol Toxicol; 2003 Feb; 92(2):71-80. PubMed ID: 12747576
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyl radical formation following methamphetamine administration to rats.
Kita T; Takahashi M; Kubo K; Wagner GC; Nakashima T
Pharmacol Toxicol; 1999 Sep; 85(3):133-7. PubMed ID: 10522753
[TBL] [Abstract][Full Text] [Related]
7. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
Miller DB; O'Callaghan JP; Ali SF
Ann N Y Acad Sci; 2000 Sep; 914():194-207. PubMed ID: 11085321
[TBL] [Abstract][Full Text] [Related]
8. Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice.
Kita T; Paku S; Takahashi M; Kubo K; Wagner GC; Nakashima T
Neuropharmacology; 1998 Sep; 37(9):1177-84. PubMed ID: 9833648
[TBL] [Abstract][Full Text] [Related]
9. The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum.
Robinson TE; Yew J; Paulson PE; Camp DM
Neurosci Lett; 1990 Mar; 110(1-2):193-8. PubMed ID: 1691471
[TBL] [Abstract][Full Text] [Related]
10. Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity.
Battaglia G; Fornai F; Busceti CL; Lembo G; Nicoletti F; De Blasi A
J Neurochem; 2003 Jul; 86(2):413-21. PubMed ID: 12871582
[TBL] [Abstract][Full Text] [Related]
11. Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implications for the prevention of methamphetamine-induced neurotoxic damage.
Imam SZ; Islam F; Itzhak Y; Slikker W; Ali SF
Ann N Y Acad Sci; 2000 Sep; 914():157-71. PubMed ID: 11085318
[TBL] [Abstract][Full Text] [Related]
12. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity.
Dluzen DE; McDermott JL; Darvesh AS
Neuroscience; 2010 Jun; 167(4):985-93. PubMed ID: 20211701
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
Bourque M; Liu B; Dluzen DE; Di Paolo T
Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264
[TBL] [Abstract][Full Text] [Related]
14. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity.
Battaglia G; Fornai F; Busceti CL; Aloisi G; Cerrito F; De Blasi A; Melchiorri D; Nicoletti F
J Neurosci; 2002 Mar; 22(6):2135-41. PubMed ID: 11896153
[TBL] [Abstract][Full Text] [Related]
15. Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey.
Melega WP; Raleigh MJ; Stout DB; Lacan G; Huang SC; Phelps ME
Brain Res; 1997 Aug; 766(1-2):113-20. PubMed ID: 9359594
[TBL] [Abstract][Full Text] [Related]
16. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.
Nishikawa T; Mataga N; Takashima M; Toru M
Eur J Pharmacol; 1983 Mar; 88(2-3):195-203. PubMed ID: 6133769
[TBL] [Abstract][Full Text] [Related]
17. Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity.
Battaglia G; Gesi M; Lenzi P; Busceti CL; Soldani P; Orzi F; Rampello L; Nicoletti F; Ruggieri S; Fornai F
Ann N Y Acad Sci; 2002 Jun; 965():254-66. PubMed ID: 12105101
[TBL] [Abstract][Full Text] [Related]
18. Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.
Itzhak Y; Ali SF
Ann N Y Acad Sci; 2002 Jun; 965():127-35. PubMed ID: 12105090
[TBL] [Abstract][Full Text] [Related]
19. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.
Cass WA; Manning MW
J Neurosci; 1999 Sep; 19(17):7653-60. PubMed ID: 10460271
[TBL] [Abstract][Full Text] [Related]
20. Effect of amphetamine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice.
Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A
Neuropharmacology; 1986 Aug; 25(8):927-30. PubMed ID: 3490630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
